The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

IgG4-Related Pancreatic Disease (Type 1 Autoimmune Pancreatitis)

Pancreatic manifestation of IgG4-related disease characterized by diffuse or focal pancreatic enlargement, sausage-like appearance, narrow main pancreatic duct, elevated serum IgG4, and dramatic response to corticosteroid therapy.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is IgG4-Related Pancreatic Disease (Type 1 Autoimmune Pancreatitis)?

IgG4-related pancreatic disease, also called type 1 autoimmune pancreatitis (AIP), is a fibroinflammatory subtype of IgG4-related disease confined to or starting in the pancreas, with characteristic histology of dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis, and obliterative phlebitis.

Diagnosis is based on the HISORt or international consensus criteria combining histology, imaging (diffuse sausage-like enlargement with peripheral capsule-like rim and irregular narrowing of main pancreatic duct), serology (elevated IgG4 typically over 135 mg/dL), other organ involvement, and response to steroids.

Critical differential diagnosis is pancreatic adenocarcinoma; misdiagnosis may lead to unnecessary Whipple surgery in benign disease or delayed cancer treatment, so multidisciplinary review including endoscopic ultrasound-guided fine-needle biopsy is essential.

Symptoms

Painless obstructive jaundice from intrapancreatic bile duct stricture or pancreatic head mass
Recent-onset diabetes mellitus or worsening of existing diabetes due to islet involvement
Mild epigastric or back pain, nausea, weight loss, fatigue
Steatorrhea and exocrine pancreatic insufficiency in long-standing or untreated disease
Findings of synchronous IgG4-related involvement of bile ducts (sclerosing cholangitis), salivary glands, lacrimal glands, retroperitoneum, kidneys, or lungs
Incidental imaging finding of diffuse pancreatic enlargement with capsule-like rim

Risk Factors

Male sex, typical age over 60 years
Personal or family history of allergy or atopic disease
Coexistent IgG4-related disease in other organs (sclerosing cholangitis, retroperitoneal fibrosis, dacryoadenitis, sialadenitis)
Smoking, possibly increasing fibroinflammatory susceptibility
HLA haplotype associations and selected genetic predispositions reported in some populations
Higher risk of recurrence with multiorgan involvement, very high serum IgG4, or proximal IgG4-sclerosing cholangitis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New onset painless jaundice with pancreatic mass on imaging — urgent referral to pancreatobiliary unit before any surgical intervention
  • Known autoimmune pancreatitis with relapsing jaundice, abdominal pain, or new diabetes — gastroenterology review for relapse
  • Acute cholangitis or biliary sepsis on background sclerosing cholangitis — emergency endoscopic biliary drainage
  • Severe weight loss, anemia, or red flags suggesting cancer despite IgG4 features — multidisciplinary review with biopsy
  • Long-term follow-up patient with steroid side effects (hyperglycemia, osteoporosis, infection) — coordinated care with primary care and specialist

Treatment Methods

01
Induction therapy with oral prednisolone 0.6–1 mg/kg/day for 2–4 weeks, then gradual taper over 3–6 months, with monitoring of clinical, biochemical, and imaging response
02
Endoscopic biliary stenting in patients with severe obstructive jaundice prior to or alongside steroid initiation, depending on cholangitis risk
03
Maintenance immunosuppression with low-dose prednisolone, azathioprine, mycophenolate, or rituximab in relapsing disease, multiorgan involvement, or steroid intolerance
04
Rituximab as B-cell depleting therapy for refractory or relapsing IgG4-related pancreatic disease, especially with associated sclerosing cholangitis
05
Long-term surveillance for relapse, pancreatic exocrine and endocrine insufficiency, malignancy risk (pancreatic and extrapancreatic), and bone health under chronic steroid therapy

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.